Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS

Clinical trial NCT07238686 · RECRUITING

Trial details

NCT number: NCT07238686
Sponsor: Beijing 302 Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2025-06-20
Primary completion: 2030-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.